Selegiline is an antidepressant and anti-Parkinson's agent. Orally it is used as an adjunct to levodopa/carbidopa therapy for Parkinson's disease; transdermally it is used for major depressive disorder. Off label it is used for ADHD; negative symptoms of schizophrenia and extrapyramidal symptoms.
| Reasons taken |
# of patients
Efficacy
|
Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Parkinson's Disease PD | 155 |
|
|
|
|
|
27 |
| Stiffness/Spasticity | 9 |
|
1 | ||||
| Other | 8 |
|
|
|
3 | ||
| disease-related symptoms | 3 | 0 | |||||
| Depression | 3 |
|
|
3 | |||
| Fatigue | 2 |
|
1 |
See all 166 patients currently taking Selegiline
Mouse over the table for more information
Top 10 dosages based on patients currently taking Selegiline. See all 21 dosages ►
| 6 mg/24 hr all the time (24/7) | daily | 0.1 mg daily | 0.5 mg daily | 1 mg daily | 1.25 mg daily | 1.5 daily | 1.5 mg daily | 2.25 mg daily | 2.5 mg daily | 3 mg daily | 5 mg daily | 5 mg one time | 6 mg/24 hr daily | 9 mg/24 hr daily | 10 mg daily | 12 mg/24 hr daily | 15 mg daily | 20 mg daily | 40 mg daily | 125 mg daily | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1
|
6
|
1
|
2
|
1
|
11
|
1
|
1
|
2
|
18
|
1
|
32
|
1
|
1
|
1
|
77
|
1
|
4
|
2
|
1
|
1
|
||
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Did not seem to work
|
23 | 30% |
|
|
Other
|
21 | 27% |
|
|
Doctor's advice
|
20 | 26% |
|
|
Side effects too severe
|
15 | 19% |
|
|
Personal research
|
6 | 8% |
|
|
Course of treatment ended
|
3 | 4% |
|
|
Expense
|
2 | 3% |
|
|
Not indicated
|
2 | 3% |
|
|
Change in health plan coverage
|
1 | 1% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on March 19, 2010.